OpenLegislation

Paragraph 64

Original text. Later amendments are not shown.

In regulation 87 (post authorisation requirements in relation to UK marketing authorisations with paediatric aspects and advanced therapy medicinal products), in the inserted regulation 78B (post authorisation requirements in relation to UK marketing authorisations for advanced therapy medicinal products)—

(a)

in the heading to the regulation for “UK marketing authorisations” substitute “UKMA(GB)”;

(b)

for “UK marketing authorisation” in each place it appears substitute “UKMA(GB)”.